KerenOsmanMD

PubMed

• CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma.
  Tyler D'Ovidio, Kathryn Ciccolini, Matko Kalac, Keren Osman, Amir Steinberg> ;Cureus. 2023 Sep 1
• 3 citations
  Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
  Marshall McKenna, Narendranath Epperla, Armin Ghobadi, Jieqi Liu, Aleksandr Lazaryan, Uroosa Ibrahim, Caron A Jacobson, Seema G Naik, Loretta Nastoupil, Sayan Mullick ...> ;British Journal of Haematology. 2023 Jul 1
• 1 citations
  CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
  Uroosa Ibrahim, Claude Bassil, Julio C Chavez, Farhad Khimani, Michael D Jain, Frederick L Locke, Keren Osman, Aleksandr Lazaryan> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Oct 1
• 15 citations
  A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
  Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, Robert L Gottlieb, Keren Osman, Abhijit Duggal, Mary E Marks, Jonathan Hupf, Eustace Fernandes, Bradley G...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Feb 1
• 1 citations
  Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.
  Cara A Rosenbaum, Umut Özbek, Larysa Sanchez, Jonathan Lagdameo, Alex Abrahams, Hani Hassoun, Oscar Lahoud, Ruben Niesvizky, Heather J Landau, Keren Osman> ;Blood Advances. 2022 Sep 27
• 15 citations
  Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
  Mahmoud Elsawy, Julio C Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D Rudzki, Saurabh Dahiya, Kath...> ;Blood. 2022 Nov 24
• 3 citations
  Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019.
  Stacey-Ann Whittaker Brown, Camelia Iancu-Rubin, Adam Aboelela, Alex Abrahams, Elizabeth Burke, Tiffany Drummond, Fred Grossman, Silviu Itescu, Jonathan Lagdameo, Jung...> ;Cytotherapy. 2022 Aug 1
• 45 citations
  COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter.
  Ankur Varma, Satyajit Kosuri, Celalettin Ustun, Uroosa Ibrahim, Jonathan Moreira, Michael R. Bishop, Sunita Nathan, Jayesh Mehta, Daniel Moncayo, Joseph Heng, Keren Os...> ;Leukemia. 2020 Aug 14
• 26 citations
  Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study.
  Suzanne Lentzsch, Galina G Lagos, Raymond L. Comenzo, Jeffrey A. Zonder, Keren Osman, Samuel Pan, Silva Pregja, Vaishali Sanchorawala, Heather Landau> ;Journal of Clinical Oncology. 2020 Feb 21
• 2 citations
  Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
  Suzanne Lentzsch, Galina G Lagos, Raymond L. Comenzo, Jeffrey A. Zonder, Silva Pregja, Keren Osman, Wei-Yann Tsai, Heather Landau, Vaishali Sanchorawala> ;Amyloid. 2019 Jul 25
• 10 citations
  Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Valida...
  Eduardo Pozo, José M. Castellano, Anubhav Kanwar, Rajiv Deochand, Mireia Castillo-Martin, Pablo Pazos-López, Carlos Gonzalez-Lengua, Keren Osman, Matthew D. Cham, Carl...> ;Journal of Cardiac Failure. 2017 Aug 1
• 84 citations
  Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation
  Nina Shah, Natalie S. Callander, Siddhartha Ganguly, Zartash Gul, Mehdi Hamadani, Luciano J. Costa, Salyka Sengsayadeth, Muneer H. Abidi, Parameswaran Hari, Mohamad Mo...> ;Biology of Blood and Marrow Transplantation. 2015 Jul 1
• 16 citations
  Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment
  Alfred Adomako, Veronica Calvo, Noa Biran, Keren Osman, Ajai Chari, James C. Paton, Adrienne W. Paton, Kateri A. Moore, Denis M. Schewe, Julio A. Aguirre-Ghiso> ;BMC Cancer. 2015 May 30
• 35 citations
  Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis
  Eduardo Pozo, Anubhav Kanwar, Rajiv Deochand, José M. Castellano, Tara Naib, Pablo Pazos-López, Keren Osman, Matthew D. Cham, Jagat Narula, Valentin Fuster, Javier Sanz> ;Heart. 2014 Jul 10
• 11 citations
  Safety and Efficacy of Triplet Regimens in Newly Diagnosed Light Chain Amyloidosis
  Ajai Chari, Kevin Barley, Sundar Jagannath, Keren Osman> ;Clinical Lymphoma, Myeloma & Leukemia. 2013 Feb 1
• Retrospective analysis of prognosticators in patients with relapsed Hodgkin’s Lymphoma treated with autologous transplant: results of a single center
  Aisha Masood, Amir Steinberg, Erin Moshier, Adriana K. Malone, Eileen Scigliano, Jacqueline Nieto, Keren Osman, Celia Grosskreutz, Luis Isola, Joshua Brody> ;Medical Oncology. 2013 Jan 6
• 75 citations
  Combination strategies to enhance antitumor ADCC.
  Holbrook E Kohrt, Roch Houot, Aurélien Marabelle, Hearn Jay Cho, Keren Osman, Matthew J. Goldstein, Ronald Levy, Joshua Brody> ;Immunotherapy. 2012 May 29
• 30 citations
  Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.
  Brian M Elliott, Steven Peti, Keren Osman, Eileen Scigliano, David Lee, Luis Isola, Lale Kostakoglu> ;European Journal of Haematology. 2011 Apr 1
• 8 citations
  Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
  Keren Osman, Brian M Elliott, John Mandeli, Eileen Scigliano, Adriana K. Malone, Luis Isola, Celia Grosskreutz> ;American Journal of Hematology. 2010 Apr 1
• 6 citations
  Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
  Yelena Sinitsyn, Adriana K. Malone, John Mandeli, Celia Grosskreutz, Keren Osman, Eileen Scigliano, Patricia A. Shi, Luis Isola> ;Cytotherapy. 2009 Aug 13
• 6 citations
  A case report of secondary autograft failure due to Gaucher disease.
  Jennifer Carreiro, Manisha Balwani, Celia Grosskreutz, Luis Isola, Adriana K. Malone, Eileen Scigliano, Keren Osman> ;American Journal of Hematology. 2008 Dec 1
• 5 citations
  Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin.
  Celia Grosskreutz, Eileen Scigliano, Keren Osman, Luis Isola> ;Transplantation. 2007 Sep 15
• 336 citations
  Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
  , , , , , , , , , , , , , , , , > ;The Journal of Experimental Medicine. 2005 May 2
• 160 citations
  Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.
  Joseph Krasovsky, Keren Osman, Matthew D. Geller> ;The Journal of Experimental Medicine. 2003 Dec 1
• 54 citations
  Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma
  Cyrus V. Hedvat, Raymond L. Comenzo, Julie Teruya-Feldstein, Adam B. Olshen, Scott Ely, Keren Osman, Yana Zhang, Nagesh Kalakonda, Stephen D. Nimer> ;British Journal of Haematology. 2003 Sep 1
• Join now to see all

Abstracts/Posters

• A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
  Keren Osman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
  Keren Osman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase 1 study of elotuzumab in combination with autologous stem cell transplantation and lenalidomide maintenance for multiple myeloma. 
  2019 ASCO Annual Meeting - 6/1/2019